Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement

Authors: Miranda I Teboh-Ewungkem, Jemal Mohammed-Awel, Frederick N Baliraine, Scott M Duke-Sylvester

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

The use of intermittent preventive treatment in pregnant women (IPTp), children (IPTc) and infant (IPTi) is an increasingly popular preventive strategy aimed at reducing malaria risk in these vulnerable groups. Studies to understand how this preventive intervention can affect the spread of anti-malarial drug resistance are important especially when there is human movement between neighbouring low and high transmission areas. Because the same drug is sometimes utilized for IPTi and for symptomatic malaria treatment, distinguishing their individual roles on accelerating the spread of drug resistant malaria, with or without human movement, may be difficult to isolate experimentally or by analysing data. A theoretical framework, as presented here, is thus relevant as the role of IPTi on accelerating the spread of drug resistance can be isolated in individual populations and when the populations are interconnected and interact.

Methods

A previously published model is expanded to include human movement between neighbouring high and low transmission areas, with focus placed on the malaria parasites. Parasite fitness functions, determined by how many humans the parasites can infect, are used to investigate how fast resistance can spread within the neighbouring communities linked by movement, when the populations are at endemic equilibrium.

Results

Model simulations indicate that population movement results in resistance spreading fastest in high transmission areas, and the more complete the anti-malarial resistance the faster the resistant parasite will tend to spread through a population. Moreover, the demography of infection in low transmission areas tends to change to reflect the demography of high transmission areas. Additionally, when regions are strongly connected the rate of spread of partially resistant parasites (R1) relative to drug sensitive parasites (RS), and fully resistant parasites (R2) relative to partially resistant parasites (R1) tend to behave the same in both populations, as should be expected.

Conclusions

In fighting anti-malarial drug resistance, different drug resistance monitoring and management policies are needed when the area in question is an isolated high or low transmission area, or when it is close and interacting with a neighbouring high or low transmission area, with human movement between them.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: World Malaria Report 2013. 2013, Geneva: World Health Organization WHO: World Malaria Report 2013. 2013, Geneva: World Health Organization
2.
go back to reference Gosling RD, Cairns ME, Chico RM, Chandramohan D: Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther. 2010, 8: 589-606. 10.1586/eri.10.36.CrossRefPubMed Gosling RD, Cairns ME, Chico RM, Chandramohan D: Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther. 2010, 8: 589-606. 10.1586/eri.10.36.CrossRefPubMed
3.
go back to reference Hastings IM, Watkins WM, White NJ: The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci. 2002, 357: 505-519. 10.1098/rstb.2001.1036.PubMedCentralCrossRefPubMed Hastings IM, Watkins WM, White NJ: The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci. 2002, 357: 505-519. 10.1098/rstb.2001.1036.PubMedCentralCrossRefPubMed
4.
go back to reference Watkins WM, Mosobo M: Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg. 1993, 87: 75-78. 10.1016/0035-9203(93)90431-O.CrossRefPubMed Watkins WM, Mosobo M: Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg. 1993, 87: 75-78. 10.1016/0035-9203(93)90431-O.CrossRefPubMed
5.
go back to reference Klein E, Smith D, Boni MF, Laxminarayan R: Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malar J. 2008, 7: 67-10.1186/1475-2875-7-67.PubMedCentralCrossRefPubMed Klein E, Smith D, Boni MF, Laxminarayan R: Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malar J. 2008, 7: 67-10.1186/1475-2875-7-67.PubMedCentralCrossRefPubMed
6.
go back to reference White NJ: Preventing antimalarial drug resistance through combinations. Drug Resist Updat. 1998, 1: 3-9. 10.1016/S1368-7646(98)80208-2.CrossRefPubMed White NJ: Preventing antimalarial drug resistance through combinations. Drug Resist Updat. 1998, 1: 3-9. 10.1016/S1368-7646(98)80208-2.CrossRefPubMed
7.
go back to reference White NJ, Pongtavornpinyo W: The de novo selection of drug resistant malaria parasites. Proc R Soc Lond B. 2003, 270: 545-554. 10.1098/rspb.2002.2241.CrossRef White NJ, Pongtavornpinyo W: The de novo selection of drug resistant malaria parasites. Proc R Soc Lond B. 2003, 270: 545-554. 10.1098/rspb.2002.2241.CrossRef
8.
go back to reference Artzy-Randrup Y, Alonso D, Pascual M: Transmission intensity and drug resistance in malaria population dynamics: implications for climate change. PLoS One. 2010, 5: e13588-10.1371/journal.pone.0013588.PubMedCentralCrossRefPubMed Artzy-Randrup Y, Alonso D, Pascual M: Transmission intensity and drug resistance in malaria population dynamics: implications for climate change. PLoS One. 2010, 5: e13588-10.1371/journal.pone.0013588.PubMedCentralCrossRefPubMed
9.
go back to reference Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC, Kivumbi GW: Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop Med Int Health. 2006, 11: 115-124. 10.1111/j.1365-3156.2005.01518.x.CrossRefPubMed Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC, Kivumbi GW: Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop Med Int Health. 2006, 11: 115-124. 10.1111/j.1365-3156.2005.01518.x.CrossRefPubMed
10.
go back to reference Talisuna AO, Okello PE, Erhart A, Coosemans M, D’Alessandro U: Intensity of malaria transmission and the spread of Plasmodium falciparum-resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg. 2007, 77 (Suppl 6): 170-180.PubMed Talisuna AO, Okello PE, Erhart A, Coosemans M, D’Alessandro U: Intensity of malaria transmission and the spread of Plasmodium falciparum-resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg. 2007, 77 (Suppl 6): 170-180.PubMed
11.
go back to reference Hastings IM: A model for the origins and spread of drug-resistant malaria. Parasitology. 1997, 115: 133-141. 10.1017/S0031182097001261.CrossRefPubMed Hastings IM: A model for the origins and spread of drug-resistant malaria. Parasitology. 1997, 115: 133-141. 10.1017/S0031182097001261.CrossRefPubMed
12.
go back to reference Gatton ML, Hogarth W, Saul A: Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections. Parasitology. 2003, 123: 537-546. Gatton ML, Hogarth W, Saul A: Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections. Parasitology. 2003, 123: 537-546.
14.
go back to reference Cohen S, McGregor IA, Carrington S: Gamma-globulin and acquired immunity to human malaria. Nature. 1961, 192: 733-737. 10.1038/192733a0.CrossRefPubMed Cohen S, McGregor IA, Carrington S: Gamma-globulin and acquired immunity to human malaria. Nature. 1961, 192: 733-737. 10.1038/192733a0.CrossRefPubMed
15.
16.
go back to reference White NJ: Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia. 1999, 41: 301-308.PubMed White NJ: Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia. 1999, 41: 301-308.PubMed
17.
go back to reference Mackinnon MJ, Hastings IM: The evolution of multiple drug resistance in malaria parasites. Trans R Soc Trop Med Hyg. 1998, 92: 188-195. 10.1016/S0035-9203(98)90745-3.CrossRefPubMed Mackinnon MJ, Hastings IM: The evolution of multiple drug resistance in malaria parasites. Trans R Soc Trop Med Hyg. 1998, 92: 188-195. 10.1016/S0035-9203(98)90745-3.CrossRefPubMed
18.
go back to reference O’Meara WP, Smith DL, McKenzie FE: Potential impact of intermittent preventive treatment (IPT) on spread of drug resistant malaria. PLoS Med. 2006, 3: 633-642. O’Meara WP, Smith DL, McKenzie FE: Potential impact of intermittent preventive treatment (IPT) on spread of drug resistant malaria. PLoS Med. 2006, 3: 633-642.
19.
go back to reference Omumbo J, Ouma J, Rapouda B, Craig MH, Le Sueur D, Snow RW: Mapping malaria transmission intensity using geographical information systems (GIS): an example from Kenya. Ann Trop Med Parasitol. 1998, 92: 7-21.CrossRefPubMed Omumbo J, Ouma J, Rapouda B, Craig MH, Le Sueur D, Snow RW: Mapping malaria transmission intensity using geographical information systems (GIS): an example from Kenya. Ann Trop Med Parasitol. 1998, 92: 7-21.CrossRefPubMed
20.
go back to reference Bonizzoni M, Afrane Y, Baliraine FN, Amenya DA, Githeko AK, Yan G: Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya. Infect Genet Evol. 2009, 9: 806-812. 10.1016/j.meegid.2009.04.015.PubMedCentralCrossRefPubMed Bonizzoni M, Afrane Y, Baliraine FN, Amenya DA, Githeko AK, Yan G: Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya. Infect Genet Evol. 2009, 9: 806-812. 10.1016/j.meegid.2009.04.015.PubMedCentralCrossRefPubMed
21.
go back to reference Shanks GD, Biomndo K, Guyatt HL, Snow RW: Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg. 2005, 99: 71-74. 10.1016/j.trstmh.2004.04.001.PubMedCentralCrossRefPubMed Shanks GD, Biomndo K, Guyatt HL, Snow RW: Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg. 2005, 99: 71-74. 10.1016/j.trstmh.2004.04.001.PubMedCentralCrossRefPubMed
22.
go back to reference Green MD, van Eijk AM, van ter Kuile FO, Ayisi JG, Parise ME, Kager PA, Nahlen BL, Steketee R, Nettey H: Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis. 2007, 196: 1403-1408. 10.1086/522632.CrossRefPubMed Green MD, van Eijk AM, van ter Kuile FO, Ayisi JG, Parise ME, Kager PA, Nahlen BL, Steketee R, Nettey H: Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis. 2007, 196: 1403-1408. 10.1086/522632.CrossRefPubMed
23.
go back to reference Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S: Population pharmacokinetic and pharmacodynamic modeling of the antimalarial chemotherapy chlorproguanil/dapsone. Br J Clin Pharmacol. 2006, 61: 289-300. 10.1111/j.1365-2125.2005.02567.x.PubMedCentralCrossRefPubMed Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S: Population pharmacokinetic and pharmacodynamic modeling of the antimalarial chemotherapy chlorproguanil/dapsone. Br J Clin Pharmacol. 2006, 61: 289-300. 10.1111/j.1365-2125.2005.02567.x.PubMedCentralCrossRefPubMed
24.
go back to reference Stepniewska K, White NJ: Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother. 2008, 52: 1589-1596. 10.1128/AAC.00903-07.PubMedCentralCrossRefPubMed Stepniewska K, White NJ: Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother. 2008, 52: 1589-1596. 10.1128/AAC.00903-07.PubMedCentralCrossRefPubMed
25.
go back to reference Dent AE, Chelimo K, Sumba PO, Spring MD, Crabb BS, Moormann AM, Tisch DJ, Kazura JW: Temporal stability of naturally acquired immunity to merozoite surface protein-1 in Kenyan adults. Malar J. 2009, 8: 162-10.1186/1475-2875-8-162.PubMedCentralCrossRefPubMed Dent AE, Chelimo K, Sumba PO, Spring MD, Crabb BS, Moormann AM, Tisch DJ, Kazura JW: Temporal stability of naturally acquired immunity to merozoite surface protein-1 in Kenyan adults. Malar J. 2009, 8: 162-10.1186/1475-2875-8-162.PubMedCentralCrossRefPubMed
26.
go back to reference Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV: Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg. 2003, 69: 558-563.PubMed Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV: Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg. 2003, 69: 558-563.PubMed
28.
go back to reference Struik SS, Riley EM: Does malaria suffer from lack of memory?. Immunol Rev. 2004, 201: 268-290. 10.1111/j.0105-2896.2004.00181.x.CrossRefPubMed Struik SS, Riley EM: Does malaria suffer from lack of memory?. Immunol Rev. 2004, 201: 268-290. 10.1111/j.0105-2896.2004.00181.x.CrossRefPubMed
29.
go back to reference Zoghi S, Mehrizi AA, Raeisi A, Haghdoost AA, Turki H, Safari R, Kahanali AA, Zakeri S: Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J. 2012, 11: 126-10.1186/1475-2875-11-126.PubMedCentralCrossRefPubMed Zoghi S, Mehrizi AA, Raeisi A, Haghdoost AA, Turki H, Safari R, Kahanali AA, Zakeri S: Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J. 2012, 11: 126-10.1186/1475-2875-11-126.PubMedCentralCrossRefPubMed
30.
go back to reference Pongtavornpinyo W, Yeung S, Hastings I, Dondorp A, Day N, White N: Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malar J. 2008, 7: 229-10.1186/1475-2875-7-229.PubMedCentralCrossRefPubMed Pongtavornpinyo W, Yeung S, Hastings I, Dondorp A, Day N, White N: Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malar J. 2008, 7: 229-10.1186/1475-2875-7-229.PubMedCentralCrossRefPubMed
31.
go back to reference Bell AS, Huijben S, Paaijmans KP, Sim GS, Chan BH, Nelson WA, Read AF: Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria. PLoS One. 2012, 7: e37172-10.1371/journal.pone.0037172. doi:10.1371/journal.pone.0037172PubMedCentralCrossRefPubMed Bell AS, Huijben S, Paaijmans KP, Sim GS, Chan BH, Nelson WA, Read AF: Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria. PLoS One. 2012, 7: e37172-10.1371/journal.pone.0037172. doi:10.1371/journal.pone.0037172PubMedCentralCrossRefPubMed
32.
go back to reference Bloland P: Drug Resistance in Malaria. 2001, Geneva: World Health Organization, WHO/CDS/CSR/DRS/2001.4 Bloland P: Drug Resistance in Malaria. 2001, Geneva: World Health Organization, WHO/CDS/CSR/DRS/2001.4
34.
go back to reference Hindmarsh AC: ODEPACK, A systematized collection of ODE solvers. IMACS Transaction on Scientific Computing. Edited by: Stepleman RS. 1983, North-Holland, Amsterdam, 55-64. Hindmarsh AC: ODEPACK, A systematized collection of ODE solvers. IMACS Transaction on Scientific Computing. Edited by: Stepleman RS. 1983, North-Holland, Amsterdam, 55-64.
35.
go back to reference Petzold LR: Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations. Siam J Sci Stat Comput. 1983, 4: 136-148. 10.1137/0904010.CrossRef Petzold LR: Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations. Siam J Sci Stat Comput. 1983, 4: 136-148. 10.1137/0904010.CrossRef
36.
go back to reference Winstanley P, Watkins W, Muhia D, Szwandt S, Amukoye E, Marsh K: Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Trans R Soc Trop Med Hyg. 1997, 91: 322-327. 10.1016/S0035-9203(97)90093-6.CrossRefPubMed Winstanley P, Watkins W, Muhia D, Szwandt S, Amukoye E, Marsh K: Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Trans R Soc Trop Med Hyg. 1997, 91: 322-327. 10.1016/S0035-9203(97)90093-6.CrossRefPubMed
37.
go back to reference Winstanley PA, Watkins WM, Newton C, Nevill C, Mberu E, Warn PA, Waruiru CM, Mwangi IN, Warrell DA, Marsh K: The disposition of oral and intramuscular pyrimethamine sulfadoxine in Kenyan children with high parasitemia but clinically non-severe falciparum malaria. Brit J Clin Pharmacol. 1992, 33: 143-148. 10.1111/j.1365-2125.1992.tb04016.x.CrossRef Winstanley PA, Watkins WM, Newton C, Nevill C, Mberu E, Warn PA, Waruiru CM, Mwangi IN, Warrell DA, Marsh K: The disposition of oral and intramuscular pyrimethamine sulfadoxine in Kenyan children with high parasitemia but clinically non-severe falciparum malaria. Brit J Clin Pharmacol. 1992, 33: 143-148. 10.1111/j.1365-2125.1992.tb04016.x.CrossRef
38.
go back to reference Hastings IM, Watkins WM: Intensity of malaria transmission and the evolution of drug resistance. Acta Trop. 2005, 94: 218-229. 10.1016/j.actatropica.2005.04.003.CrossRefPubMed Hastings IM, Watkins WM: Intensity of malaria transmission and the evolution of drug resistance. Acta Trop. 2005, 94: 218-229. 10.1016/j.actatropica.2005.04.003.CrossRefPubMed
39.
go back to reference Pindolia DK, Garcia AJ, Huang Z, Smith DL, Alegana VA, Noor AM, Snow RW, Tatem AJ: The demographics of human and malaria movement and migration patterns in East Africa. Malar J. 2013, 12: 397-10.1186/1475-2875-12-397.PubMedCentralCrossRefPubMed Pindolia DK, Garcia AJ, Huang Z, Smith DL, Alegana VA, Noor AM, Snow RW, Tatem AJ: The demographics of human and malaria movement and migration patterns in East Africa. Malar J. 2013, 12: 397-10.1186/1475-2875-12-397.PubMedCentralCrossRefPubMed
40.
go back to reference Wesolowski A, Eagle N, Tatem AJ, Smith DL, Noor AM, Snow RW, Buckee CO: Quantifying the impact of human mobility on malaria. Science. 2012, 338: 267-270. 10.1126/science.1223467.PubMedCentralCrossRefPubMed Wesolowski A, Eagle N, Tatem AJ, Smith DL, Noor AM, Snow RW, Buckee CO: Quantifying the impact of human mobility on malaria. Science. 2012, 338: 267-270. 10.1126/science.1223467.PubMedCentralCrossRefPubMed
41.
go back to reference Williams HA, Durrheim D, Shretta R: The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004, 19: 356-370. 10.1093/heapol/czh051.CrossRefPubMed Williams HA, Durrheim D, Shretta R: The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004, 19: 356-370. 10.1093/heapol/czh051.CrossRefPubMed
42.
go back to reference Bryant T: Role of knowledge in public health and health promotion policy change. Health Promot Int. 2002, 17: 1- Bryant T: Role of knowledge in public health and health promotion policy change. Health Promot Int. 2002, 17: 1-
43.
go back to reference Mubyazi GM, Gonzalez-Block MA: Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J. 2005, 4: 51-10.1186/1475-2875-4-51.PubMedCentralCrossRefPubMed Mubyazi GM, Gonzalez-Block MA: Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J. 2005, 4: 51-10.1186/1475-2875-4-51.PubMedCentralCrossRefPubMed
44.
go back to reference Shretta R, Omumbo J, Rapuoda B, Snow RW: Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000, 5: 755-764. 10.1046/j.1365-3156.2000.00643.x.CrossRefPubMed Shretta R, Omumbo J, Rapuoda B, Snow RW: Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000, 5: 755-764. 10.1046/j.1365-3156.2000.00643.x.CrossRefPubMed
45.
go back to reference Tiono AB, Dicko A, Ndububa DA, Agbenyega T, Pitmang S, Awobusuyi J, Pamba A, Duparc S, Goh LE, Harrell E, Carter N, Ward SA, Greenwood B, Winstanley PA: Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 2009, 81: 969-978. 10.4269/ajtmh.2009.09-0351.CrossRefPubMed Tiono AB, Dicko A, Ndububa DA, Agbenyega T, Pitmang S, Awobusuyi J, Pamba A, Duparc S, Goh LE, Harrell E, Carter N, Ward SA, Greenwood B, Winstanley PA: Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 2009, 81: 969-978. 10.4269/ajtmh.2009.09-0351.CrossRefPubMed
46.
go back to reference Teboh-Ewungkem MI, Ngwa GA, Ngonghala CN: Models and proposals for malaria: a review. Math Popul Stud. 2013, 20: 57-81. 10.1080/08898480.2013.777237.CrossRef Teboh-Ewungkem MI, Ngwa GA, Ngonghala CN: Models and proposals for malaria: a review. Math Popul Stud. 2013, 20: 57-81. 10.1080/08898480.2013.777237.CrossRef
48.
go back to reference Ngwa GA, Shu WS: A mathematical model for endemic malaria with variable human and mosquito populations. Math Comput Model. 2000, 32: 747-763. 10.1016/S0895-7177(00)00169-2.CrossRef Ngwa GA, Shu WS: A mathematical model for endemic malaria with variable human and mosquito populations. Math Comput Model. 2000, 32: 747-763. 10.1016/S0895-7177(00)00169-2.CrossRef
49.
go back to reference Teboh-Ewungkem MI, Podder CN, Gumel AB: Mathematical study of the role of gametocytes and an imperfect vaccine on malaria transmission dynamics. Bull Math Biol. 2010, 72: 63-93. 10.1007/s11538-009-9437-3.CrossRefPubMed Teboh-Ewungkem MI, Podder CN, Gumel AB: Mathematical study of the role of gametocytes and an imperfect vaccine on malaria transmission dynamics. Bull Math Biol. 2010, 72: 63-93. 10.1007/s11538-009-9437-3.CrossRefPubMed
50.
go back to reference Ngwa GA: On the population dynamics of the malaria vector. Bull Math Biol. 2006, 68: 2161-2189. 10.1007/s11538-006-9104-x.CrossRefPubMed Ngwa GA: On the population dynamics of the malaria vector. Bull Math Biol. 2006, 68: 2161-2189. 10.1007/s11538-006-9104-x.CrossRefPubMed
51.
go back to reference Ngonghala CN, Ngwa GA, Teboh-Ewungkem MI: Periodic oscillations and backward bifurcation in a model for the dynamics of malaria transmission. Math Biosci. 2013, 240: 45-62.CrossRef Ngonghala CN, Ngwa GA, Teboh-Ewungkem MI: Periodic oscillations and backward bifurcation in a model for the dynamics of malaria transmission. Math Biosci. 2013, 240: 45-62.CrossRef
52.
53.
go back to reference Nourridine S, Ngwa GA, Teboh-Ewungkem MI: A mathematical model of the population dynamics of disease-transmitting vectors with spatial consideration. J Biol Dyn. 2011, 5: 335-365. 10.1080/17513758.2010.508540.CrossRef Nourridine S, Ngwa GA, Teboh-Ewungkem MI: A mathematical model of the population dynamics of disease-transmitting vectors with spatial consideration. J Biol Dyn. 2011, 5: 335-365. 10.1080/17513758.2010.508540.CrossRef
54.
go back to reference Ngwa GA, Wankah TT, Fomboh-Nforba MY, Ngonghala CN, Teboh-Ewungkem MI: On a reproductive stage-structured model for the population dynamics of the malaria vector. Bull Math Biol. 2014, 76: 2476-2516. 10.1007/s11538-014-0021-0.CrossRefPubMed Ngwa GA, Wankah TT, Fomboh-Nforba MY, Ngonghala CN, Teboh-Ewungkem MI: On a reproductive stage-structured model for the population dynamics of the malaria vector. Bull Math Biol. 2014, 76: 2476-2516. 10.1007/s11538-014-0021-0.CrossRefPubMed
55.
go back to reference Teboh Ewungkem MI, Yuster T: A within vector mathematical model of Plasmodium falciparum and implications of incomplete fertilization on optimal gametocyte sex ratio. J Theor Biol. 2010, 264: 273-286. 10.1016/j.jtbi.2009.12.017.CrossRefPubMed Teboh Ewungkem MI, Yuster T: A within vector mathematical model of Plasmodium falciparum and implications of incomplete fertilization on optimal gametocyte sex ratio. J Theor Biol. 2010, 264: 273-286. 10.1016/j.jtbi.2009.12.017.CrossRefPubMed
56.
go back to reference Teboh-Ewungkem MI, Wang M: Male fecundity and optimal gametocyte sex ratios for Plasmodium falciparum during incomplete fertilization. J Theor Biol. 2012, 307: 183-192.CrossRefPubMed Teboh-Ewungkem MI, Wang M: Male fecundity and optimal gametocyte sex ratios for Plasmodium falciparum during incomplete fertilization. J Theor Biol. 2012, 307: 183-192.CrossRefPubMed
Metadata
Title
The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement
Authors
Miranda I Teboh-Ewungkem
Jemal Mohammed-Awel
Frederick N Baliraine
Scott M Duke-Sylvester
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-428

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.